Reaction to results · all yearsrose on day 0 in 0 of 1 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 5 Sept 2026 | -2.9% | +16.9% | — | — |
| Average | -2.9% | +16.9% | — | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSV| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
CSVDelivery percentage
Over the last 20 sessions MOLBIO settled 15.0% of its traded quantity, which is low for an NSE equity.
What delivery percentage measuresScan the whole market on delivery
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -0.15% | +21.30% | +32.23% | — | — | — |
Valuation
CSVOwnership
CSVQuarterly results · consolidated
CSV| Q1 FY27 | |
|---|---|
| Revenue (₹ Cr) | 408.4 |
| YoY chg | — |
| Net profit (₹ Cr) | 52.7 |
| YoY chg | — |
| Net margin | 12.9% |
| EPS | 5.21 |
Shareholding over time
CSVOne quarter on file; a trend needs two.
- Promoter
- 41.29%
- Public
- 58.71%
- Promoter change
- —
- Filed
- 20 Aug 2026
- FII
- 1.51%
- DII
- 16.37%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV| Q1 FY27 | Trend | |
|---|---|---|
| Revenue from operations | 408.4 | |
| Other income | 3.1 | |
| Total income | 411.5 | |
| Total expenses | 335.6 | |
| └ Finance costs | 10.7 | |
| └ Depreciation | 17.1 | |
| Profit before tax | 75.9 | |
| Tax expense | 23.2 | |
| Net profit | 52.7 | |
| EPS | 5.21 | |
| Net margin | 12.92% | |
| PBT margin | 18.59% | |
| Tax rate | 30.52% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 5 Sept 2026.
1 quarter on file; a year-on-year comparison needs five.
MOLBIO at a glance
- MOLBIO closed at ₹1,501.1 on 6 Oct 2026, -0.15% on the day.
- Delivery was 14.1% of traded quantity on 6 Oct 2026, the 51st percentile of its own 35 sessions with a reading (20-session average 15.0%, 1-year average 16.5%).
- Market capitalisation is ₹17,299 crore, with no positive trailing earnings for a P/E.
- Q1 FY27 results (consolidated, filed 5 Sept 2026): revenue ₹408 crore, net profit ₹53 crore; the price moved -2.9% on the first session after.
- Promoters held 41.29% at 14 Aug 2026.
About
CSVPrices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Equipment & Supplies
CSV- POLYMEDPoly Medicure Limited1,633.80+0.88%
- TARSONSTarsons Products Limited331.65-1.28%
- FISCHERFischer Medical Ventures Limited33.14+1.04%
- LAXMIDENTLLaxmi Dental Limited190.53-0.01%
- FABTECHFabtech Technologies Limited141.04-0.59%
- GKBGKB61.76-1.91%
All Healthcare Equipment & Supplies stocks on the NSEAll Healthcare stocks on the NSE